Proactiveinvestors Australia Feedback PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia Feedback PLC RSS feed en Mon, 22 Jul 2019 00:58:52 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Outcome of strategic review and trading update ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190710070003_14142593/ Wed, 10 Jul 2019 16:00:03 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190710070003_14142593/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190610092851_14104604/ Mon, 10 Jun 2019 18:28:51 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190610092851_14104604/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190607100758_14103077/ Fri, 07 Jun 2019 19:07:58 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190607100758_14103077/ <![CDATA[RNS press release - Trading update ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190425070006_14050993/ Thu, 25 Apr 2019 16:00:06 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190425070006_14050993/ <![CDATA[RNS press release - Feedback Medical CEO appointed Feedback plc CEO ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190409070008_14033340/ Tue, 09 Apr 2019 16:00:08 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190409070008_14033340/ <![CDATA[RNS press release - Feedback Medical appoints Dr Tom Oakley as CEO ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190214070012_13968821/ Thu, 14 Feb 2019 18:00:12 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190214070012_13968821/ <![CDATA[RNS press release - Half-year Results ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190124070004_13944811/ Thu, 24 Jan 2019 18:00:04 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190124070004_13944811/ <![CDATA[RNS press release - Result of AGM ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190123140229_13944484/ Thu, 24 Jan 2019 01:02:29 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20190123140229_13944484/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181130170002_13887723/ Sat, 01 Dec 2018 04:00:02 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181130170002_13887723/ <![CDATA[RNS press release - Final Results ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181129143736_13885690/ Fri, 30 Nov 2018 01:37:36 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181129143736_13885690/ <![CDATA[RNS press release - Feedback retains industry standard certification ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181122125947_13877403/ Thu, 22 Nov 2018 23:59:47 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181122125947_13877403/ <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181119145648_13872313/ Tue, 20 Nov 2018 01:56:48 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181119145648_13872313/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181119114935_13872022/ Mon, 19 Nov 2018 22:49:35 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181119114935_13872022/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181116091635_13869946/ Fri, 16 Nov 2018 20:16:35 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181116091635_13869946/ <![CDATA[RNS press release - Result of General Meeting ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181115113558_13868588/ Thu, 15 Nov 2018 22:35:58 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181115113558_13868588/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181101151138_13851989/ Fri, 02 Nov 2018 02:11:38 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181101151138_13851989/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181031170001_13850175/ Thu, 01 Nov 2018 04:00:01 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181031170001_13850175/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181031161506_13850101/ Thu, 01 Nov 2018 03:15:06 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181031161506_13850101/ <![CDATA[RNS press release - Notice of General Meeting ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181029144440_13846362/ Tue, 30 Oct 2018 01:44:40 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181029144440_13846362/ <![CDATA[RNS press release - Proposed placing and subscription to raise £1.375m ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181025070005_13841596/ Thu, 25 Oct 2018 17:00:05 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181025070005_13841596/ <![CDATA[RNS press release - Expansion of European customer base ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181022070008_13836507/ Mon, 22 Oct 2018 17:00:08 +1100 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181022070008_13836507/ <![CDATA[RNS press release - Trading update ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181003070004_13814026/ Wed, 03 Oct 2018 16:00:04 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181003070004_13814026/ <![CDATA[RNS press release - Appointment of Joint Broker ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181001070006_13810164/ Mon, 01 Oct 2018 16:00:06 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20181001070006_13810164/ <![CDATA[RNS press release - TexRAD® ordered by Samsung Medical Centre in Seoul ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180910070007_13783874/ Mon, 10 Sep 2018 16:00:07 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180910070007_13783874/ <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180817140200_13760033/ Fri, 17 Aug 2018 23:02:00 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180817140200_13760033/ <![CDATA[RNS press release - First GE Healthcare order for TexRAD® ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180815070004_13755666/ Wed, 15 Aug 2018 16:00:04 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180815070004_13755666/ <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180801131951_13740022/ Wed, 01 Aug 2018 22:19:51 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180801131951_13740022/ <![CDATA[RNS press release - Directorate Change ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180720070003_13725037/ Fri, 20 Jul 2018 16:00:03 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180720070003_13725037/ <![CDATA[News - Feedback boss David Crabb leaves with immediate effect ]]> https://www.proactiveinvestors.com.au/companies/news/201207/feedback-boss-david-crabb-leaves-with-immediate-effect-201207.html David Crabb, the chief executive of Feedback plc (LON:FDBK), has left the specialist medical imaging group with immediate effect.

Crabb only joined in February but is stepping down “in order to devote more time to his other business interests”.

READ: New Feedback boss sets out his stall

The search for a new boss is underway and Dr Alastair Riddell will assume the role of executive chairman in the meantime.

“On behalf of the board I would like to acknowledge and thank David for his contribution to Feedback,” said Riddell.

“We wish him well with his future endeavours.”

Feedback, which owns a smart piece of software that analyses medical images to reveal features that are not always evident to the human eye, will make a further announcement in due course.

]]>
Fri, 20 Jul 2018 07:27:00 +1000 https://www.proactiveinvestors.com.au/companies/news/201207/feedback-boss-david-crabb-leaves-with-immediate-effect-201207.html
<![CDATA[RNS press release - Joint broker update ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180706070003_13707841/ Fri, 06 Jul 2018 16:00:03 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180706070003_13707841/ <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180629152055_13700019/ Sat, 30 Jun 2018 00:20:55 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180629152055_13700019/ <![CDATA[RNS press release - Grant of Options and Director/PDMR Dealing ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180627070005_13694851/ Wed, 27 Jun 2018 16:00:05 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180627070005_13694851/ <![CDATA[RNS press release - Result of General Meeting ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180622141026_13690504/ Fri, 22 Jun 2018 23:10:26 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180622141026_13690504/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180608103654_13672654/ Fri, 08 Jun 2018 19:36:54 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180608103654_13672654/ <![CDATA[RNS press release - Notice of General Meeting ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180607070505_13670248/ Thu, 07 Jun 2018 16:05:05 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180607070505_13670248/ <![CDATA[RNS press release - Revised strategy to build a global company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180607070005_13670082/ Thu, 07 Jun 2018 16:00:05 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180607070005_13670082/ <![CDATA[News - Feedback’s new boss sets out his stall after strategic review ]]> https://www.proactiveinvestors.com.au/companies/news/198431/feedbacks-new-boss-sets-out-his-stall-after-strategic-review-198431.html The new boss of Feedback plc (LON:FDBK) has outlined his plans for the medical imaging technology group after completing a strategic review.

David Crabb was brought in back in February and, along with the new members of his executive team, has been looking at ways to simplify and streamline the AIM-listed firm.

READ: Feedback tweaks structure and board

“Our vision is to lead global innovation in quantitative medical imaging analysis, and since February 2018 I have been resolutely focused on making the necessary organisational and operational changes for long-term growth,” said Crabb.

“The new team and organisational structure will allow us to leverage our deep domain expertise to continue to build our market share.”

He added: “As with any period of change, there may be an impact on operational developments in the short-term, however all efforts are now focused on delivering the four areas of our strategy and I look forward to reporting more progress during 2018.”

Feedback told investors back in April that it was merging two of its subsidiaries – Cambridge Computed Imaging and TexRAD – into a new entity called Feedback Medical.

Crabb added on Thursday that he wants to build on the company’s “impressive” customer base by expanding into new global markets and exploring the use of the TexRAD technology in the pharma industry.

Develop TexRAD and Cadran platforms

TexRAD Lung – a piece of software that analyses medical images of lung lesions – is Feedback’s most advanced product.

Three major UK hospitals are currently trialling it, after which the company will build in any modifications they suggest and then market it properly to its existing customer base. The plan is to also develop TexRAD for use in other indications.

Feedback’s time and money has generally been directed toward TexRAD, but Crabb wants to devote more resources towards the firm’s Cadran medical imaging technology platform.

Cadran has a lot of competition from expensive rivals, but the company wants to target developing countries and other global markets which might be interested in a more cost-effective option.

]]>
Thu, 07 Jun 2018 08:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198431/feedbacks-new-boss-sets-out-his-stall-after-strategic-review-198431.html
<![CDATA[RNS press release - Appointment of new Medical Director ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180601070007_13662777/ Fri, 01 Jun 2018 16:00:07 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180601070007_13662777/ <![CDATA[News - Feedback shares jump as it appoints new medical director ]]> https://www.proactiveinvestors.com.au/companies/news/198069/feedback-shares-jump-as-it-appoints-new-medical-director-198069.html Feedback PLC (LON:FDBK) shares jumped in mid-afternoon trading Friday after it appointed Professor Rory Shaw as medical director of its subsidiary company, Feedback Medical Limited.

The AIM-listed medical imaging group said Shaw is a highly experienced NHS executive with a strong track record in strategy development and international relations.

READ: Feedback Medical unit signs new 2-year deal to support Royal Papworth Hospital’s scan analysis

In November 2013, he was appointed as medical director of Healthcare UK, part of the Department of International Trade, to lead the NHS International Development Team.

Prior to this, Shaw was a medical director in the NHS for over 15 years, latterly at North West London Hospitals Trust, and previously at Royal Berkshire Foundation Trust and Hammersmith Hospitals Trust. 

He has also held national roles as non-executive of the NHS Litigation Authority and previously as the first chairman of the National Patient Safety Agency.

David Crabb, Feedback chief executive, said: "With a unique combination of clinical and international engagement experience, Professor Shaw brings a highly complementary skill-set to the team. His clinical input, together with Dr Balaji Ganeshan's market expertise, will underpin our product development strategy following the first CE marked release of the TexRAD technology. Furthermore, Professor Shaw's international reach will be invaluable as we continue to pursue opportunities to increase TexRAD and Cadran platform technology sales globally."

Rory Shaw, medical director of Feedback Medical Limited, said: "The TexRAD technology provides a way of obtaining a new level of information about cancers by using Artificial Intelligence to undertake an in-depth analysis of CT scans and other images. The next exciting phase is to understand how this new information can be used in the clinical care of patients with diseases such as lung cancer, to enable better disease staging and thus to enable more effective cancer treatment."

Feedback shares were up 5.5% at 2.88p.

-- Adds share price --

]]>
Fri, 01 Jun 2018 07:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198069/feedback-shares-jump-as-it-appoints-new-medical-director-198069.html
<![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180510092747_13636077/ Thu, 10 May 2018 18:27:47 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180510092747_13636077/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180504180902_13631368/ Sat, 05 May 2018 03:09:02 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180504180902_13631368/ <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180501070006_13624857/ Tue, 01 May 2018 16:00:06 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180501070006_13624857/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180430170001_13624483/ Tue, 01 May 2018 02:00:01 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180430170001_13624483/ <![CDATA[RNS press release - Two-year contract with Royal Papworth Hospital ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180427070006_13620891/ Fri, 27 Apr 2018 16:00:06 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180427070006_13620891/ <![CDATA[News - Feedback Medical unit signs new 2-year deal to support Royal Papworth Hospital’s scan analysis ]]> https://www.proactiveinvestors.com.au/companies/news/195923/feedback-medical-unit-signs-new-2-year-deal-to-support-royal-papworth-hospitals-scan-analysis-195923.html Feedback plc (LON:FDBK) has announced that its subsidiary company, Feedback Medical Limited, has signed a two-year agreement with Royal Papworth Hospital NHS Foundation Trust to support and maintain its Cadran picture archiving communication system (PACS), which provides decision support for scan analysis.

The AIM-listed firm said the Trust is due to move from the existing site in Papworth Everard to a new custom-built hospital on the Cambridge Biomedical Campus during 2018.

READ: Feedback shares jump on news of distribution agreement with General Electric Healthcare

Feedback Medical has been providing PACS technology and support to the Trust for over 15 years. The company said the new agreement will provide continued support for the existing systems and data management and will ensure a smooth transition and continuity of service as the Trust moves to the new Papworth Hospital.

David Crabb, chief executive officer of Feedback, said: “The development of the new site and facilities is an exciting new chapter in the history of the world-leading expertise of Royal Papworth Hospital and we are pleased to be part of this journey.”

The company said Cadran is installed in a number of NHS sites in the East of England and represents an unseen but vital part of medical imaging, allowing scans to be easily stored, retrieved and analysed by medical practitioners to better diagnose disease and assess patient management.

]]>
Fri, 27 Apr 2018 07:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195923/feedback-medical-unit-signs-new-2-year-deal-to-support-royal-papworth-hospitals-scan-analysis-195923.html
<![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425140548_13618488/ Wed, 25 Apr 2018 23:05:48 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425140548_13618488/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425140032_13618479/ Wed, 25 Apr 2018 23:00:32 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425140032_13618479/ <![CDATA[RNS press release - Distribution agreement with GE Healthcare ]]> https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425070012_13617318/ Wed, 25 Apr 2018 16:00:12 +1000 https://www.proactiveinvestors.com.au/companies/rns/353/LSE20180425070012_13617318/ <![CDATA[News - Feedback shares jump on news of distribution agreement with General Electric Healthcare ]]> https://www.proactiveinvestors.com.au/companies/news/195709/feedback-shares-jump-on-news-of-distribution-agreement-with-general-electric-healthcare-195709.html Feedback PLC (LON:FDBK) was a top gainer in early trading Wednesday as it secured a software licence and distribution agreement for its TexRAD technology with General Electric Healthcare (GEHC), a subsidiary of US conglomerate General Electric (NYSE:GE).

The AIM-listed medical imaging company said the agreement granted GEHC non-exclusive global rights to offer Feedback’s TexRAD texture analysis software for medical imaging research applications.

WATCH: Restructure sees Feedback PLC positioned for growth

The group added that India would be the first market in which TexRAD would be offered under the new agreement through Wipro – GE Healthcare India.

Feedback said the development of sales and customer engagement in India via GEHC would build on its existing customer base and that it would also be working with other GEHC affiliates to identify additional territories for its TexRAD offering.

David Crabb, Feedback chief executive, said in a statement: "We are delighted to be working with GE Healthcare as a major provider of medical imaging equipment and services in India, demonstrated by their commitment and investment in this market.

He added: “This global distribution agreement will further our international expansion, ensuring that our technology continues to be used by the world's leading institutions to expedite research in this important field."

Feedback shares were up 46.7% at 2.7p.

]]>
Wed, 25 Apr 2018 07:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195709/feedback-shares-jump-on-news-of-distribution-agreement-with-general-electric-healthcare-195709.html
<![CDATA[Media files - Restructure sees Feedback Plc positioned for growth ]]> https://www.proactiveinvestors.com.au/companies/stocktube/9108/restructure-sees-feedback-plc-positioned-for-growth-9108.html Thu, 19 Apr 2018 14:55:00 +1000 https://www.proactiveinvestors.com.au/companies/stocktube/9108/restructure-sees-feedback-plc-positioned-for-growth-9108.html